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HIV replication and the immune response to the virus
lead to a state of generalized immune activation, which
drives the pathogenesis of HIV disease. HIV-induced
immune activation results in increased T-cell turnover
(production and destruction), increased death of T cells, a
decline in the size of the CD4+ T-cell pool, and a state of
activation-induced immunodeficiency. In many HIV-
infected individuals, these phenomena can be reversed or
mitigated with effective antiretroviral therapy (ART),
which blunts HIV replication and can reduce plasma lev-
els of viremia to undetectable levels. Recent data from our
laboratory have demonstrated fundamental differences
between viremic and aviremic individuals with regard to
the physiologic state of the resting CD4+ T-cell reservoir of
HIV and the phenotype and function of T cells, B cells and
natural killer (NK) cells. In terms of the CD4+ T-cell reser-
voir, resting cells in viremic versus aviremic individuals
differentially express certain genes associated with HIV
replication and are continually poised to express virus as
a result of continual activation related to viremia; thus,
true latency likely does not exist in these patients. We had
previously reported that much greater stability exists in
aviremic individuals, suggesting the presence of a truly
latent reservoir of virus in this population. However,
recent data indicate that the normal physiologic process
of low-level immune activation in aviremic individuals
sustained the low level turnover and propagation of the
latent HIV reservoir. Previously, we have demonstrated
that HIV-mediated hyperactivation induces the terminal
differentiation of B cells. More recently, we have deter-
mined that certain B-cell genes are upregulated in HIV-
viremic individuals as compared with HIV-aviremic indi-
viduals. Many of these genes are associated with terminal
B-cell differentiation and death by apoptosis. Recent data
indicate that there is a balance between expression of sur-
vival and apoptotic genes in HIV-infected individuals that
is impacted by the presence and level of viremia. In
viremic individuals we also have characterized a popula-
tion of aberrantly activated CD56- NK cells that manifest
lower-than-normal expression of Natural Cytotoxicity
Receptors and a normal or increased expression of inhib-
itory NK receptors. This dichotomy is reflected in
decreased cytotoxic function and decreased secretion of
TNF-alpha and interferon-gamma. In addition, NK cells
from viremic individuals express Fas on their surfaces at
significantly increased levels, and are more susceptible to
apoptosis upon exposure to sFASL. Furthermore, viremia
impacts the NK cell-dendritic cell interactions that are crit-
ical to normal immune responsiveness. Taken together,
our data indicate that HIV pathogenesis involves both
direct and indirect effects of HIV and a relentless cycle of
aberrant immune activation that drives the disease proc-
ess in HIV-infected individuals.
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